Naidoo Jerusha, Young Deborah
Department of Pharmacology and Clinical Pharmacology and Centre for Brain Research, University of Auckland, Auckland 1023, New Zealand.
Neurol Res Int. 2012;2012:595410. doi: 10.1155/2012/595410. Epub 2012 Jan 5.
Substantial progress has been made in the development of novel gene therapy strategies for central nervous system (CNS) disorders in recent years. However, unregulated transgene expression is a significant issue limiting human applications due to the potential side effects from excessive levels of transgenic protein that indiscriminately affect both diseased and nondiseased cells. Gene regulation systems are a tool by which tight tissue-specific and temporal regulation of transgene expression may be achieved. This review covers the features of ideal regulatory systems and summarises the mechanics of current exogenous and endogenous gene regulation systems and their utility in the CNS.
近年来,在中枢神经系统(CNS)疾病的新型基因治疗策略开发方面取得了重大进展。然而,由于转基因蛋白过量水平可能产生的副作用会不加区分地影响患病细胞和未患病细胞,转基因表达不受调控是限制人类应用的一个重大问题。基因调控系统是一种工具,通过它可以实现转基因表达的严格组织特异性和时间调控。本综述涵盖了理想调控系统的特征,并总结了当前外源和内源基因调控系统的机制及其在中枢神经系统中的应用。